Bertelsmann-backed paywall management software provider Zephr is set to be acquired by Zuora in a $44m deal while Meituan co-led a $875m round for EV battery producer Sunwoda.

Public markets

Third Harmonic Bio, the US-based allergy and inflammatory therapy developer backed by pharmaceutical firm Novartis, has filed to list on the Nasdaq Global Market. The company had closed a $105m series B round in December 2021 and still had $113m cash on hand as of June this year, according to the securities filing. Novartis owns a 9.4% stake having licensed several patents to Third Harmonic.


Subscription management tool provider Zuora has agreed to acquire…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.